‘We are Kind Consumer, a pioneering healthcare research and development company, specialising in respiratory drug delivery and tobacco harm reduction.’
Kind Consumer, founded by Alex Hearn in 2006, is a healthcare research and development company focused on inhalation technologies. Our innovation programmes are directed towards pioneering novel inhalation devices that intend to fulfil significant health problems including tobacco harm reduction, tobacco dependence and respiratory drug delivery.
‘We house significant expertise in medical engineering, development and performance.’
Kind Consumer has developed a pipeline of respiratory drug delivery technologies. Under the direction of Dr. Chris Moyses, its lead product, the Voke 0.45mg Inhaler was licensed in 2014 by the Medicines Healthcare and Regulatory agency after its initial application in 2012. The technology is a nicotine inhaler which will aim to rival licensed nicotine replacement therapies and unlicensed electronic cigarettes.